MassMutual Private Wealth & Trust’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$37.6K Sell
432
-86
-17% -$5.19K ﹤0.01% 885
2026
Q1
$20.9K Sell
518
-79
-13% -$2.95K ﹤0.01% 1064
2025
Q4
$20.8K Sell
597
-25
-4% -$1.96K ﹤0.01% 1101
2025
Q3
$51.7K Sell
622
-31
-5% -$2.24K ﹤0.01% 793
2025
Q2
$47.9K Buy
653
+33
+5% +$2.39K ﹤0.01% 798
2025
Q1
$70.8K Buy
620
+313
+102% +$19.1K ﹤0.01% 641
2024
Q4
$15.5K Buy
307
+7
+2% +$367 ﹤0.01% 1107
2024
Q3
$13.9K Buy
300
+11
+4% +$391 ﹤0.01% 1024
2024
Q2
$9.39K Sell
289
-15
-5% -$411 ﹤0.01% 1118
2024
Q1
$7.66K Sell
304
-4,008
-93% -$94.7K ﹤0.01% 1118
2023
Q4
$140K Buy
4,312
+4,007
+1,314% +$110K ﹤0.01% 413
2023
Q3
$8.31K Hold
305
﹤0.01% 1075
2023
Q2
$6.79K Buy
305
+69
+29% +$1.59K ﹤0.01% 1097
2023
Q1
$5.11K Buy
+236
New +$5.17K ﹤0.01% 1147
2022
Q4
Sell
-31
Closed -$1K 1680
2022
Q3
$1K Buy
+31
New +$830 ﹤0.01% 1390
2018
Q3
Sell
-103
Closed -$1.62K 994
2018
Q2
$1.62K Hold
103
﹤0.01% 914
2018
Q1
$1.69K Buy
+103
New +$1.91K ﹤0.01% 855

Other funds holding CORT

MassMutual Private Wealth & Trust's CORT Position: Q2 2026 in Review

MassMutual Private Wealth & Trust reduced its Corcept Therapeutics (CORT) stake by 17% in Q2 2026, selling an estimated $5.19K and leaving 432 shares worth $37.6K. The position accounts for ﹤0.01% of the portfolio, ranked #885.

MassMutual Private Wealth & Trust first reported a position in CORT in Q1 2018 and has held it in 17 quarters since. The position peaked at $140K in Q4 2023. 423 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • MassMutual Private Wealth & Trust held 432 shares of Corcept Therapeutics worth $37.6K as of Q2 2026.
  • MassMutual Private Wealth & Trust sold 86 Corcept Therapeutics shares in Q2 2026, an estimated $5.19K.
  • Corcept Therapeutics made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #885 holding.
  • MassMutual Private Wealth & Trust first reported a position in Corcept Therapeutics in Q1 2018 and has held it in 17 quarters since.
  • MassMutual Private Wealth & Trust's Corcept Therapeutics position peaked at $140K in Q4 2023.
  • 423 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.